{"product_id":"xeomin-100u","title":"XEOMIN 100U","description":"\u003cp data-pm-slice=\"1 1 []\"\u003e\u003cspan\u003eXEOMIN 100U is a \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ebotulinum neurotoxin type A formulation containing 100 LD50 Units per vial\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, manufactured by Merz and formulated \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ewithout complexing proteins\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eContaining the purified \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e150 kDa botulinum neurotoxin type A\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, XEOMIN is supplied as a lyophilized powder for solution for injection. For aesthetic use, it is indicated for the temporary improvement of moderate-to-severe upper facial lines in adults.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eKey Features\u003c\/span\u003e\u003c\/h2\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e100 LD50 Units per vial\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eBotulinum neurotoxin type A\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e150 kDa neurotoxin\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eFree from complexing proteins\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eLyophilized powder for solution for injection\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eSingle-vial presentation\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eApproved aesthetic indications covering major upper facial lines\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e1–25°C unopened storage\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e36-month shelf life\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cspan\u003eAesthetic Indications\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eXEOMIN is indicated for the temporary improvement in the appearance of moderate-to-severe upper facial lines, including:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGlabellar lines\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e associated with corrugator and\/or procerus muscle activity\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eLateral canthal lines (crow's feet)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e associated with orbicularis oculi muscle activity\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eHorizontal forehead lines\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e associated with frontalis muscle activity\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eAge ranges and exact authorized indications should follow the current product information applicable to the jurisdiction where XEOMIN is used.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eAdditional Approved Applications\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eXEOMIN also has approved therapeutic indications in various jurisdictions, including applications involving:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eChronic sialorrhea\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eUpper-limb spasticity\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eCervical dystonia\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eBlepharospasm\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eExact therapeutic indications, age groups and authorization status vary by jurisdiction and should be confirmed against the applicable current prescribing information.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eComposition\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eEach vial contains:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eClostridium Botulinum Neurotoxin Type A:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 100 LD50 Units\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eNeurotoxin Molecular Size:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 150 kDa\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eComplexing Proteins:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e None\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe formulation also contains:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eHuman Serum Albumin\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eSucrose\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003ePurified 150 kDa Formulation\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eXEOMIN contains \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e150 kDa botulinum neurotoxin type A without accessory complexing proteins\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis distinguishes its formulation from botulinum toxin preparations containing the neurotoxin together with accessory protein complexes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe biological activity units of XEOMIN are specific to the product and its assay method and are \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003enot interchangeable with the units of other botulinum toxin products\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eHow XEOMIN Works\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eBotulinum neurotoxin type A temporarily inhibits acetylcholine release from peripheral cholinergic nerve endings.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhen administered to targeted muscles, this temporarily reduces muscle activity. In aesthetic applications, this mechanism can reduce the appearance of dynamic facial lines associated with muscle contraction.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eProduct Specifications\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e XEOMIN Injection\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eActive Ingredient:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Clostridium Botulinum Neurotoxin Type A\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eStrength:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 100 LD50 Units\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eNeurotoxin:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 150 kDa\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eComplexing Proteins:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e None\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eForm:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Lyophilized powder for solution for injection\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003ePresentation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Single vial\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eQuantity:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 1 vial per box\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eUnits per Vial:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 100 LD50 Units\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eManufacturer:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Merz Pharma GmbH \u0026amp; Co. KGaA\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eKorean Export:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e South Korea\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eWhat's in the Box\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e1 × XEOMIN 100 LD50 Units vial\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eStorage \u0026amp; Handling\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eStore unopened XEOMIN at \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e1–25°C\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e in a sealed container.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe unopened product therefore \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003edoes not require refrigerated storage\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e when maintained within its labeled storage conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eShelf Life:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 36 months from the date of manufacture.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAfter reconstitution, the product may be refrigerated at \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e2–8°C for up to 24 hours\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Current Merz Korea information recommends using the prepared solution promptly because the formulation does not contain an antimicrobial preservative.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePreparation, handling and administration should follow the current XEOMIN product information and applicable professional requirements.\u003c\/span\u003e\u003c\/p\u003e","brand":"brunodermalfiller.com","offers":[{"title":"Default Title","offer_id":44438970663169,"sku":"BT0036","price":199.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0617\/7062\/9377\/files\/awdadsdaw.png?v=1789558904","url":"https:\/\/brunodermalfiller.com\/en-fr\/products\/xeomin-100u","provider":"brunodermalfiller.com","version":"1.0","type":"link"}